These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29878474)
1. An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma. Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Navarro-Triviño FJ; Gil-Montoya JA Oral Dis; 2019 May; 25(4):949-971. PubMed ID: 29878474 [TBL] [Abstract][Full Text] [Related]
2. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177 [TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864 [TBL] [Abstract][Full Text] [Related]
4. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334 [TBL] [Abstract][Full Text] [Related]
5. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Clark ES; Brown B; Whigham AS; Kochaishvili A; Yarbrough WG; Weaver AM Oncogene; 2009 Jan; 28(3):431-44. PubMed ID: 18931703 [TBL] [Abstract][Full Text] [Related]
6. Relevance of chromosomal band 11q13 in oral carcinogenesis: An update of current knowledge. Ramos-García P; Ruiz-Ávila I; Gil-Montoya JA; Ayén Á; González-Ruiz L; Navarro-Triviño FJ; González-Moles MÁ Oral Oncol; 2017 Sep; 72():7-16. PubMed ID: 28797464 [TBL] [Abstract][Full Text] [Related]
7. Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma. Sugahara K; Michikawa Y; Ishikawa K; Shoji Y; Iwakawa M; Shibahara T; Imai T Int J Oncol; 2011 Oct; 39(4):761-9. PubMed ID: 21701773 [TBL] [Abstract][Full Text] [Related]
9. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma. Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038 [TBL] [Abstract][Full Text] [Related]
11. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Liu HS; Lu HH; Lui MT; Yu EH; Shen W; Chen YP; Chang KW; Tu HF Oral Oncol; 2009 Dec; 45(12):1032-6. PubMed ID: 19666237 [TBL] [Abstract][Full Text] [Related]
12. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis. Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Gil-Montoya JA Head Neck; 2019 Jun; 41(6):1963-1978. PubMed ID: 30597652 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression. Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838 [TBL] [Abstract][Full Text] [Related]
15. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396 [TBL] [Abstract][Full Text] [Related]
16. miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene. Li Y; Zhang H; Gong H; Yuan Y; Li Y; Wang C; Li W; Zhang Z; Liu M; Liu H; Chen J J Exp Clin Cancer Res; 2018 Jul; 37(1):141. PubMed ID: 29986736 [TBL] [Abstract][Full Text] [Related]
17. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes. Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059 [TBL] [Abstract][Full Text] [Related]
18. Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion. Markwell SM; Ammer AG; Interval ET; Allen JL; Papenberg BW; Hames RA; Castaño JE; Schafer DA; Weed SA Mol Cancer Res; 2019 Apr; 17(4):987-1001. PubMed ID: 30610108 [TBL] [Abstract][Full Text] [Related]
19. Cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas. Ambrosio EP; Rosa FE; Domingues MA; Villacis RA; Coudry Rde A; Tagliarini JV; Soares FA; Kowalski LP; Rogatto SR Hum Pathol; 2011 Sep; 42(9):1221-9. PubMed ID: 21419472 [TBL] [Abstract][Full Text] [Related]
20. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer. Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]